Cargando…
Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by various pathogenic factors, which will further develop into cirrhosis or even hepatocellular carcinoma if liver injury is not intervened in time. As a diffuse progressive liver disease, its clinical mani...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071861/ https://www.ncbi.nlm.nih.gov/pubmed/35529927 http://dx.doi.org/10.1155/2022/5325431 |
_version_ | 1784700922580959232 |
---|---|
author | Nan, Yang Su, HongChan Lian, XiaoMei Wu, Juan Liu, SuJie Chen, PingPing Liu, ShuMin |
author_facet | Nan, Yang Su, HongChan Lian, XiaoMei Wu, Juan Liu, SuJie Chen, PingPing Liu, ShuMin |
author_sort | Nan, Yang |
collection | PubMed |
description | Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by various pathogenic factors, which will further develop into cirrhosis or even hepatocellular carcinoma if liver injury is not intervened in time. As a diffuse progressive liver disease, its clinical manifestations are mostly excessive deposition of collagen-rich extracellular matrix resulting in scar formation due to liver injury. Hepatic fibrosis can be caused by hepatitis B and C, fatty liver, alcohol, and rare diseases such as hemochromatosis. As the metabolic center of the body, the liver regulates various vital activities. During the development of fibrosis, it is influenced by many other factors in addition to the central event of hepatic stellate cell activation. Currently, with the increasing understanding of TCM, the advantages of TCM with multiple components, pathways, and targets have been demonstrated. In this review, we will describe the factors influencing liver fibrosis, focusing on the effects of cells, intestinal flora, iron death, signaling pathways, autophagy and angiogenesis on liver fibrosis, and the therapeutic effects of herbal medicine on liver fibrosis. |
format | Online Article Text |
id | pubmed-9071861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-90718612022-05-06 Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives Nan, Yang Su, HongChan Lian, XiaoMei Wu, Juan Liu, SuJie Chen, PingPing Liu, ShuMin Evid Based Complement Alternat Med Review Article Liver fibrosis is a pathological process of abnormal tissue proliferation in the liver caused by various pathogenic factors, which will further develop into cirrhosis or even hepatocellular carcinoma if liver injury is not intervened in time. As a diffuse progressive liver disease, its clinical manifestations are mostly excessive deposition of collagen-rich extracellular matrix resulting in scar formation due to liver injury. Hepatic fibrosis can be caused by hepatitis B and C, fatty liver, alcohol, and rare diseases such as hemochromatosis. As the metabolic center of the body, the liver regulates various vital activities. During the development of fibrosis, it is influenced by many other factors in addition to the central event of hepatic stellate cell activation. Currently, with the increasing understanding of TCM, the advantages of TCM with multiple components, pathways, and targets have been demonstrated. In this review, we will describe the factors influencing liver fibrosis, focusing on the effects of cells, intestinal flora, iron death, signaling pathways, autophagy and angiogenesis on liver fibrosis, and the therapeutic effects of herbal medicine on liver fibrosis. Hindawi 2022-04-28 /pmc/articles/PMC9071861/ /pubmed/35529927 http://dx.doi.org/10.1155/2022/5325431 Text en Copyright © 2022 Yang Nan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Nan, Yang Su, HongChan Lian, XiaoMei Wu, Juan Liu, SuJie Chen, PingPing Liu, ShuMin Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives |
title | Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives |
title_full | Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives |
title_fullStr | Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives |
title_full_unstemmed | Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives |
title_short | Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives |
title_sort | pathogenesis of liver fibrosis and its tcm therapeutic perspectives |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071861/ https://www.ncbi.nlm.nih.gov/pubmed/35529927 http://dx.doi.org/10.1155/2022/5325431 |
work_keys_str_mv | AT nanyang pathogenesisofliverfibrosisanditstcmtherapeuticperspectives AT suhongchan pathogenesisofliverfibrosisanditstcmtherapeuticperspectives AT lianxiaomei pathogenesisofliverfibrosisanditstcmtherapeuticperspectives AT wujuan pathogenesisofliverfibrosisanditstcmtherapeuticperspectives AT liusujie pathogenesisofliverfibrosisanditstcmtherapeuticperspectives AT chenpingping pathogenesisofliverfibrosisanditstcmtherapeuticperspectives AT liushumin pathogenesisofliverfibrosisanditstcmtherapeuticperspectives |